Long-term efficacy and safety of luspatercept for the treatment of anaemia in patients with transfusion-dependent β-thalassaemia (BELIEVE): final results from a phase 3 randomised trialMaria Domenica Cappellini, Alì Taher, Hong-Keng Liew et al.|The Lancet Haematology|2025Cited by 17
P1466: EFFECT OF LUSPATERCEPT ON BONE MINERAL DENSITY IN PATIENTS WITH BETA‑THALASSEMIA ENROLLED IN THE PHASE 3 BELIEVE TRIALThomas D. Coates, Alì Taher, Maria Domenica Cappellini et al.|HemaSphere|2023Cited by 1
Efficacy and Safety of Luspatercept in Patients with HbE/β-Thalassemia from the BELIEVE Study: A Subgroup AnalysisKevin H.M. Kuo, Vip Viprakasit, Pranee Sutcharitchan et al.|Blood|2023Cited by 1